Cargando…
Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589384/ https://www.ncbi.nlm.nih.gov/pubmed/32770604 http://dx.doi.org/10.1111/iju.14346 |
| _version_ | 1783600566582116352 |
|---|---|
| author | Kawahara, Takashi |
| author_facet | Kawahara, Takashi |
| author_sort | Kawahara, Takashi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7589384 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75893842020-10-30 Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer Kawahara, Takashi Int J Urol Editorial Comment John Wiley and Sons Inc. 2020-08-08 2020-10 /pmc/articles/PMC7589384/ /pubmed/32770604 http://dx.doi.org/10.1111/iju.14346 Text en © 2020 The Author. International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Comment Kawahara, Takashi Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title | Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title_full | Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title_fullStr | Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title_full_unstemmed | Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title_short | Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| title_sort | editorial comment to considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589384/ https://www.ncbi.nlm.nih.gov/pubmed/32770604 http://dx.doi.org/10.1111/iju.14346 |
| work_keys_str_mv | AT kawaharatakashi editorialcommenttoconsiderationsfortheuseofgonadotropinreleasinghormoneagonistsandantagonistsinpatientswithprostatecancer |